AbbVie Inc. (ABBV) vs Novo Nordisk A/S (NVO)
NVO leads on 12 of 15 compared metrics.
A side-by-side comparison of AbbVie Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 16, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs NVO
growth of $100 · last 14yABBV +533.8%NVO +170.2%ABBV compounded faster
ABBV NVO
ABBV vs NVO: by the numbers
- •ABBV is the larger company ($391.86B vs $193.53B market cap).
- •NVO trades at the lower earnings multiple (10.19 vs 108.66 P/E).
- •NVO converts more revenue to profit (37.14% vs 5.79% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 4.59% CAGR).
- •NVO pays the higher dividend yield (4.14% vs 3.04%).
Which is better, ABBV or NVO?
Metric tally: ABBV 3 · NVO 12It depends on what you're optimizing for:
ValueNVO(lower P/E)
GrowthNVO(faster 5Y revenue CAGR)
IncomeNVO(higher dividend yield)
QualityNVO(higher ROIC)
Metrics side by side
Valuation
| Metric | ABBV | NVO |
|---|---|---|
| P/E ratio | 108.66 | 10.19● |
| P/S ratio | 6.26 | 3.78● |
| P/B ratio | 14.30 | 6.19● |
| PEG ratio | — | 8.17 |
| EV / EBITDA | 26.98 | 7.35● |
| FCF yield | 5.31%● | 2.50% |
Profitability
| Metric | ABBV | NVO |
|---|---|---|
| Gross margin | 70.68% | 81.83%● |
| Operating margin | 27.60% | 45.21%● |
| Net margin | 5.79% | 37.14%● |
| ROE | 13.23% | 60.74%● |
| ROIC | 12.97% | 29.53%● |
Dividends
| Metric | ABBV | NVO |
|---|---|---|
| Dividend yield | 3.04% | 4.14%● |
| Payout ratio | 284.39% | 49.80% |
Growth (annualized)
| Metric | ABBV | NVO |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 20.73%● |
| EPS CAGR (5Y) | -2.79% | 19.59%● |
| FCF CAGR (5Y) | 3.24%● | -5.86% |
| Total return CAGR (5Y) | 18.31%● | 2.95% |
Frequently asked
- Which is better, ABBV or NVO?
- It depends on your goal. value: NVO (lower P/E); growth: NVO (faster 5Y revenue CAGR); income: NVO (higher dividend yield); quality: NVO (higher ROIC). Across all compared metrics, NVO leads 12 to 3.
- Is ABBV or NVO cheaper?
- On trailing earnings, NVO is cheaper: ABBV trades at a 108.66 P/E and NVO at 10.19.
- Which has grown faster, ABBV or NVO?
- Over the past five years, NVO grew revenue faster — ABBV at a 4.59% CAGR versus NVO at 20.73%.
- Does ABBV or NVO pay a bigger dividend?
- ABBV yields 3.04% and NVO yields 4.14% based on trailing dividends and the latest price.
- Is ABBV or NVO more profitable?
- NVO runs the higher net margin — ABBV at 5.79% versus NVO at 37.14%.
- Which has been the better investment, ABBV or NVO?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.60% versus NVO at 7.84%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioNovo Nordisk A/S P/E ratioAbbVie dividend yieldNovo Nordisk A/S dividend yieldAbbVie ROENovo Nordisk A/S ROEAbbVie operating marginNovo Nordisk A/S operating marginAbbVie revenue growthNovo Nordisk A/S revenue growthAbbVie free cash flowNovo Nordisk A/S free cash flow
AbbVie & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 16, 2026.